Δευτέρα 23 Ιανουαρίου 2017

Confirmed benefit for treating advanced NSCLC, though fifth of patients abstain

Non-small cell lung cancer (NSCLC) patients with advanced disease receiving standard of care treatment have a higher overall survival (OS) than similar patients not receiving treatment. Lung cancer is the leading cause of cancer deaths worldwide, causing...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2k7LfdE
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις